Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
5.50
-0.21 (-3.68%)
At close: Aug 28, 2025, 4:00 PM
5.47
-0.03 (-0.55%)
After-hours: Aug 28, 2025, 4:00 PM EDT
Biodexa Pharmaceuticals Market Cap
Biodexa Pharmaceuticals has a market cap or net worth of $3.41 million as of August 28, 2025. Its market cap has decreased by -59.76% in one year.
Market Cap
3.41M
Enterprise Value
2.36M
1-Year Change
-59.76%
Ranking
Category
Stock Price
$5.50
Market Cap Chart
Since October 28, 2016, Biodexa Pharmaceuticals's market cap has decreased from $55.80M to $3.41M, a decrease of -93.89%. That is a compound annual growth rate of -27.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2025 | 3.54M | 50.38% |
| Dec 31, 2024 | 2.35M | -66.49% |
| Dec 29, 2023 | 7.02M | 64.98% |
| Dec 30, 2022 | 4.26M | -67.32% |
| Dec 31, 2021 | 13.02M | -43.85% |
| Dec 31, 2020 | 23.19M | 52.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.09B |
| Johnson & Johnson | 425.77B |
| AbbVie | 367.55B |
| UnitedHealth Group | 275.22B |
| AstraZeneca | 248.07B |
| Novo Nordisk | 246.45B |
| Novartis AG | 245.68B |
| Abbott Laboratories | 228.80B |